McLoughlin HS - Search Results

1

Disease-associated oligodendrocyte signatures are spatiotemporally dysregulated in spinocerebellar ataxia type 3.

Schuster KH, DiFranco DM, Putka AF, Mato JP, Jarrah SI, Stec NR, Sundararajan VO, McLoughlin HS. Schuster KH, et al. Among authors: mcloughlin hs. Front Neurosci. 2023 Feb 15;17:1118429. doi: 10.3389/fnins.2023.1118429. eCollection 2023. Front Neurosci. 2023. PMID: 36875652 Free PMC article.

2

Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice.

McLoughlin HS, Moore LR, Chopra R, Komlo R, McKenzie M, Blumenstein KG, Zhao H, Kordasiewicz HB, Shakkottai VG, Paulson HL. McLoughlin HS, et al. Ann Neurol. 2018 Jul;84(1):64-77. doi: 10.1002/ana.25264. Epub 2018 Aug 6. Ann Neurol. 2018. PMID: 29908063 Free PMC article.

3

In Vivo Molecular Signatures of Cerebellar Pathology in Spinocerebellar Ataxia Type 3.

Costa MDC, Radzwion M, McLoughlin HS, Ashraf NS, Fischer S, Shakkottai VG, Maciel P, Paulson HL, Öz G. Costa MDC, et al. Among authors: mcloughlin hs. Mov Disord. 2020 Oct;35(10):1774-1786. doi: 10.1002/mds.28140. Epub 2020 Jul 4. Mov Disord. 2020. PMID: 32621646 Free PMC article.

4

Impaired Oligodendrocyte Maturation Is an Early Feature in SCA3 Disease Pathogenesis.

Schuster KH, Zalon AJ, Zhang H, DiFranco DM, Stec NR, Haque Z, Blumenstein KG, Pierce AM, Guan Y, Paulson HL, McLoughlin HS. Schuster KH, et al. Among authors: mcloughlin hs. J Neurosci. 2022 Feb 23;42(8):1604-1617. doi: 10.1523/JNEUROSCI.1954-20.2021. Epub 2022 Jan 18. J Neurosci. 2022. PMID: 35042771 Free PMC article.

5

Pathogenetic Mechanisms Underlying Spinocerebellar Ataxia Type 3 Are Altered in Primary Oligodendrocyte Culture.

Schuster KH, Putka AF, McLoughlin HS. Schuster KH, et al. Among authors: mcloughlin hs. Cells. 2022 Aug 22;11(16):2615. doi: 10.3390/cells11162615. Cells. 2022. PMID: 36010688 Free PMC article.

6

Diverse regional mechanisms drive spinocerebellar ataxia type 1 phenotypes.

Putka AF, McLoughlin HS. Putka AF, et al. Among authors: mcloughlin hs. Neuron. 2023 Feb 15;111(4):447-449. doi: 10.1016/j.neuron.2023.01.021. Neuron. 2023. PMID: 36796325 Free article.

7

Myelinating Glia: Potential Therapeutic Targets in Polyglutamine Spinocerebellar Ataxias.

Putka AF, Mato JP, McLoughlin HS. Putka AF, et al. Among authors: mcloughlin hs. Cells. 2023 Feb 13;12(4):601. doi: 10.3390/cells12040601. Cells. 2023. PMID: 36831268 Free PMC article. Review.

8

Blood neurofilament light chain levels are associated with disease progression in a transgenic SCA3 mouse model.

Mengel D, Wellik IG, Schuster KH, Jarrah SI, Wacker M, Ashraf NS, Öz G, Synofzik M, do Carmo Costa M, McLoughlin HS. Mengel D, et al. Among authors: mcloughlin hs. bioRxiv [Preprint]. 2023 Mar 1:2023.02.28.530463. doi: 10.1101/2023.02.28.530463. bioRxiv. 2023. PMID: 36909535 Free PMC article. Updated. Preprint.

9

Disease-associated oligodendrocyte signatures in neurodegenerative disease: the known and unknown.

Schuster KH, McLoughlin HS. Schuster KH, et al. Among authors: mcloughlin hs. Neural Regen Res. 2023 Oct;18(10):2192-2193. doi: 10.4103/1673-5374.368302. Neural Regen Res. 2023. PMID: 37056132 Free PMC article. No abstract available.

10

Purkinje-Enriched snRNA-seq in SCA7 Cerebellum Reveals Zebrin Identity Loss as a Central Feature of Polyglutamine Ataxias.

Bartelt LC, Switonski PM, Adamek G, Carvalho J, Duvick LA, Jarrah SI, McLoughlin HS, Scoles DR, Pulst SM, Orr HT, Hull C, Lowe CB, La Spada AR. Bartelt LC, et al. Among authors: mcloughlin hs. bioRxiv [Preprint]. 2023 May 11:2023.03.19.533345. doi: 10.1101/2023.03.19.533345. bioRxiv. 2023. PMID: 37214832 Free PMC article. Preprint.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page